Maripau Wealth Management’s Merck MRK Stock Holding History

Maripau Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,034	Closed	-$253K	–	101
2024 Q2	$253K	Buy	2,034 +165	+9%	+$21.3K	0.17%	122
2024 Q1	$247K	Buy	+1,869	New	+$230K	0.19%	114
2023 Q1	–	Sell	-2,282	Closed	-$251K	–	81
2022 Q4	$251K	Sell	2,282 -24	-1%	-$2.45K	0.26%	67
2022 Q3	$233K	Buy	+2,306	New	+$206K	0.25%	72

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Maripau Wealth Management's MRK Position: Q3 2024 in Review

Maripau Wealth Management sold out of Merck (MRK) in Q3 2024, closing a stake of 2,034 shares — an estimated $253K sold.

Maripau Wealth Management first reported a position in MRK in Q3 2022 and held it in 4 quarters. The position peaked at $253K in Q2 2024. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

Maripau Wealth Management reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
Maripau Wealth Management sold 2,034 Merck shares in Q3 2024, an estimated $253K.
Maripau Wealth Management first reported a position in Merck in Q3 2022 and held it in 4 quarters.
Maripau Wealth Management's Merck position peaked at $253K in Q2 2024.
3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Maripau Wealth Management's 13F filing for Q3 2024, filed 21 Oct 2024.